Dyne Therapeutics Inc (DYN) — Capital Reinvestment Ratio
Dyne Therapeutics Inc (DYN) has a Capital Reinvestment Ratio of 2.67x as of December 2017, meaning it reinvests 3% of its operating cash flow ($84.00 Million) in capital expenditures ($224.00 Million). Check how tangible is Dyne Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dyne Therapeutics Inc Capital Reinvestment Ratio (2010–2017)
This chart tracks Dyne Therapeutics Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Dyne Therapeutics Inc cash flow conversion.
Annual Capital Reinvestment Ratio for Dyne Therapeutics Inc (2010–2017)
Year-by-year Capital Reinvestment Ratio for Dyne Therapeutics Inc from 2010 to 2017. See cash generation quality of Dyne Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.38x | $585.00 Million | $224.00 Million | ▼ -20.6% |
| 2016 | 0.48x | $676.00 Million | $326.00 Million | ▼ -83.5% |
| 2015 | 2.93x | $94.00 Million | $275.00 Million | ▲ +422.4% |
| 2013 | 0.56x | $175.00 Million | $98.00 Million | ▼ -28.9% |
| 2010 | 0.79x | $423.00 Million | $333.00 Million | — |